Exploring state-of-the-art advances in targeted nanomedicines for managing acute and chronic inflammatory lung diseases.

MLA

Maurya, S., et al. Exploring State-of-the-Art Advances in Targeted Nanomedicines for Managing Acute and Chronic Inflammatory Lung Diseases. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1382612705&authtype=sso&custid=ns315887.

APA

Maurya, S., Srivastava, R., Arfin, S., Hawthorne, S., Jha, N., Agrawal, K., Raj, S., Rathi, B., Kumar, A., Raj, R., Agrawal, S., Paiva-Santos, A., Malik, A., Dua, K., Rana, R., Ojha, S., Jha, S., Sharma, A., Kumar, D., … Nagar, A. (2023). Exploring state-of-the-art advances in targeted nanomedicines for managing acute and chronic inflammatory lung diseases.

Chicago

Maurya, S, R Srivastava, S Arfin, S Hawthorne, Nk Jha, K Agrawal, S Raj, et al. 2023. “Exploring State-of-the-Art Advances in Targeted Nanomedicines for Managing Acute and Chronic Inflammatory Lung Diseases.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1382612705&authtype=sso&custid=ns315887.